Brett K. Haumann's Insider Trades & SAST Disclosures

Brett K. Haumann's most recent trade in Theravance Biopharma Inc was a trade of 35,672 Ordinary Shares done at an average price of $18.8 . Disclosure was reported to the exchange on Feb. 20, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Theravance Biopharma Inc
Brett K. Haumann Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.79 per share. 20 Feb 2021 35,672 242,499 (0%) 0% 18.8 670,277 Ordinary Shares
Theravance Biopharma Inc
Brett K. Haumann Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. 20 Nov 2020 4,639 278,171 (0%) 0% 17.2 79,837 Ordinary Shares
Theravance Biopharma Inc
Brett K. Haumann Chief Medical Officer Sale of securities on an exchange or to another person at price $ 18.29 per share. 20 Aug 2020 25,000 282,810 (0%) 0% 18.3 457,240 Ordinary Shares
Theravance Biopharma Inc
Brett K. Haumann Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.22 per share. 20 Aug 2020 4,646 307,810 (0%) 0% 18.2 84,650 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades